Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pevonedistat and Pembrolizumab in dMMR/MSI-H Cancers
NCT04800627Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Mar 2021
- Primary completion
- Nov 2022
- Countries
- 1
01
Overview
A Phase 2 trial of pevonedistat in solid tumor, sponsored by University of Texas MD Anderson Cancer Center. Started Mar 2021; status: terminated.
02
Drugs
pevonedistat
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04800627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04800627.